Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
7 Essential Brain Tumor Medications and Treatment Options Explained
7 Essential Brain Tumor Medications and Treatment Options Explained 2

At Liv Hospital, we know how tough brain tumor treatments can be. New discoveries in medicine have brought us advanced medications. These are changing how we care for those with brain cancer.

We’re all about giving our patients the newest and most effective treatments. A big step forward is using vorasidenib for certain brain tumors. It shows how fast this field is moving.

Our team works hard to give top-notch, patient-focused care. We make sure our patients get the best treatment for their needs. Knowing about brain tumor drugs and treatment choices is key to making smart health decisions.

Key Takeaways

  • Recent advancements in brain tumor medication are improving treatment outcomes.
  • Liv Hospital is committed to providing innovative care for patients with brain cancer.
  • Understanding available treatment options is key for patients.
  • Breakthroughs like vorasidenib are changing the treatment scene.
  • Patient-centered care is at the heart of our treatment approach.

Understanding Brain Tumors and Their Impact

cross-section of the human brain
7 Essential Brain Tumor Medications and Treatment Options Explained 3

It’s important to understand brain tumors to create effective treatment plans. These tumors can be benign or malignant. Their impact on patients varies based on type, location, and size.

Types of Brain Tumors

Brain tumors are divided into primary and metastatic types. Primary tumors start in the brain, while metastatic tumors come from other parts. Glioblastoma, a primary tumor, is aggressive and often treated with glioblastoma chemotherapy drugs.

Different types of brain tumors need different treatments. This includes surgery, radiation, and chemotherapy. For example, brain tumor chemotherapy drugs are key in fighting malignant tumors.

Common Symptoms and Diagnosis

Symptoms of brain tumors vary and depend on the tumor’s location and size. Common signs include headaches, seizures, and changes in thinking. Doctors use MRI and CT scans to diagnose, followed by a biopsy to determine the tumor type.

“Early diagnosis is key for effective treatment. Advanced imaging has greatly helped us detect tumors early.”

Why Specialized Treatment Approaches Are Necessary

Brain tumors are complex and varied, making specialized treatment approaches necessary. Treatments are tailored to each patient, considering the tumor type and overall health. For instance, gbm chemotherapy drugs are used for glioblastoma, showing the need for personalized care.

Combining various therapies under a multidisciplinary team’s guidance is vital. This ensures patients receive complete care.

The Evolution of Brain Tumor Medication

medical laboratory with advanced equipment and scientists
7 Essential Brain Tumor Medications and Treatment Options Explained 4

Brain tumor treatment has come a long way. It has moved from simple methods to advanced therapies that focus on specific molecular targets. Today, we see a big change towards personalized medicine and targeted treatments.

Historical Treatment Approaches

Old treatments for brain tumors were not very effective. Chemotherapy drugs for brain cancer were not as advanced back then. Treatments were often based on trial and error.

Carmustine (BCNU) was one of the first chemotherapy agents used. It works by messing with DNA in cancer cells. But, it didn’t work well and had bad side effects.

Developing glioblastoma drugs was hard because of the blood-brain barrier. This barrier made it hard for drugs to reach the tumor. Despite this, researchers kept looking for new treatments, like chemo tablets for brain tumors like lomustine (CCNU).

Modern Advancements in Neurological Pharmacology

Brain tumor treatment has changed a lot with new brain cancer treatment drugs. Temodar was a big step forward in treating glioblastoma. It helps slow down tumor growth and has fewer side effects.

Another big step was Avastin, which targets how tumors grow new blood vessels. This has shown to slow tumor growth and improve patient results.

  • Improved understanding of molecular mechanisms driving tumor growth
  • Development of targeted therapies with fewer side effects
  • Enhanced delivery methods, including oral chemotherapy agents

How Treatment Protocols Have Changed

Today, brain tumor treatment is more complex. It includes surgery, radiation, and chemotherapy. Combination therapies are used more often. Treatments are tailored to each patient based on their tumor type and molecular characteristics.

Our knowledge of brain tumors has grown, leading to better treatment plans. Now, treatments are more focused on precision medicine. They are guided by genetic and molecular profiles.

The evolution of brain tumor medication has brought new hope. As research keeps improving, we can expect even better treatments and care for patients.

Temozolomide (Temodar): The Frontline Brain Tumor Medication

Temozolomide, or Temodar, is a key chemotherapy drug for brain tumors. It’s used first because it works well on many brain tumors. Its way of working and how it’s given make it very useful in treating brain cancers.

How Temozolomide Works

Temozolomide stops cancer cells from growing by messing with their DNA. It makes DNA damage that kills the cells. This helps slow down tumor growth.

Dosage and Administration Protocols

The amount of temozolomide given depends on the patient’s size. It’s taken by mouth. The usual treatment plan includes a cycle followed by a break. We watch for side effects and adjust the dose as needed.

Here’s a simple table showing the dosage:

Treatment CycleDosage (mg/m)Duration (days)
Cycle 11505
Cycle 2+2005

Effectiveness for Different Tumor Types

Temozolomide works well on several brain tumors, like glioblastoma and anaplastic astrocytoma. It’s most effective in patients with specific genetic markers. We keep researching to improve how we use it for different tumors.

Bevacizumab (Avastin): Targeting Tumor Blood Vessels

Bevacizumab (Avastin) is key in fighting brain cancer. It stops new blood vessels from forming, which tumors need to grow. This way, it cuts off the nutrients and oxygen tumors need.

Mechanism of Action

Bevacizumab targets VEGF, a protein that helps blood vessels grow. It blocks VEGF from reaching its receptors on endothelial cells. This stops new blood vessels from forming, which tumors need to grow and spread.

Clinical Applications and Treatment Regimens

Bevacizumab is used for many brain tumors, like glioblastoma. It’s often given with other treatments like chemotherapy or radiation. The treatment plan depends on the tumor type, stage, and the patient’s health.

Studies show Bevacizumab can help patients live longer without their tumors getting worse. But, it’s not clear if it helps patients live longer overall.

Managing Side Effects and Complications

Bevacizumab is usually safe but can cause side effects. These include high blood pressure, protein in the urine, and feeling very tired. Serious problems like bleeding, blood clots, and holes in the stomach can also happen.

We watch patients closely for any bad effects. We adjust their treatment to keep them safe and help them get the most benefit from Bevacizumab.

Everolimus (Afinitor): mTOR Pathway Inhibition

Everolimus (Afinitor) is a new way to treat brain tumors. It works by blocking the mTOR pathway. This pathway controls how cells grow and live.

When this pathway gets out of balance, it can lead to cancer. Everolimus helps by stopping this imbalance.

Effects on Cellular Growth

Everolimus binds to FKBP-12, stopping the mTOR kinase. This stops the signals that tell cells to grow. So, it slows down tumor growth.

Tumor Types Responsive to Treatment

Everolimus works well on SEGA tumors linked to TSC. It’s also being tested on other brain tumors, like glioblastoma. How well it works depends on the tumor and the person.

Combination Therapy Approaches

Everolimus is often paired with other treatments. This mix can be more effective. Researchers are looking for the best combinations.

Tumor TypeEverolimus EfficacyCommon Combination Therapies
SEGA associated with TSCHigh response rateSurgery, mTOR inhibitors
GlioblastomaVariable responseTemozolomide, Bevacizumab
Other Brain TumorsOngoing researchVarious chemotherapies, targeted therapies

Vorasidenib: Breakthrough for IDH-Mutated Gliomas

Vorasidenib is a big step forward in treating IDH-mutated gliomas. It brings new hope to those with this tough condition. IDH-mutated gliomas are brain tumors with specific genetic changes. These changes affect the IDH enzyme, leading to tumor growth.

The Science Behind IDH Mutations

IDH mutations are key in some gliomas. The mutation creates an abnormal enzyme that changes how cells work. This leads to 2-HG, a substance that helps tumors grow. Knowing about IDH mutations helps in making targeted treatments like vorasidenib.

Clinical Trial Results and Efficacy Data

Clinical trials show vorasidenib works well for IDH-mutated gliomas. It has shown great results in slowing tumor growth and helping patients. In one study, patients on vorasidenib lived longer without their tumors getting worse than those on a placebo. This shows vorasidenib could be a key treatment for these patients.

Patient Selection Criteria

Choosing the right patients for vorasidenib is very important. Only those with IDH mutations can get the treatment. Doctors also look at the tumor’s grade, the patient’s age, and health. A team of doctors works together to decide the best treatment for each patient.

Carmustine (BCNU) and Lomustine (CCNU): Alkylating Agents

Alkylating agents like carmustine and lomustine are key in fighting brain tumors. They are essential in treating different types of brain cancers.

Mechanism and Delivery Methods

Carmustine and lomustine attach an alkyl group to cancer cells’ DNA. This stops them from copying themselves and kills the cells. It’s a main way to slow down tumor growth.

These drugs can be given in different ways. Carmustine is usually given through an IV, while lomustine is taken by mouth. The method chosen depends on the treatment plan and the patient’s needs.

Carmustine Wafers (Gliadel)

Gliadel wafers are a new way to give carmustine. They are small, dissolvable wafers put into the tumor during surgery. As they break down, they release carmustine, focusing the treatment on the tumor.

Studies show Gliadel wafers can help patients with high-grade gliomas live longer. This method reduces side effects by targeting the tumor directly.

Managing Toxicity Profiles

It’s important to manage the side effects of carmustine and lomustine to keep patients safe and treatment effective. Common side effects include nausea, vomiting, and myelosuppression.

To lessen these side effects, we adjust doses and use supportive care. We also keep an eye on blood counts and liver function to avoid serious problems.

DrugCommon Side EffectsManagement Strategies
CarmustineNausea, Vomiting, MyelosuppressionDose adjustment, Antiemetics
LomustineMyelosuppression, Fatigue, NauseaMonitoring blood counts, Supportive care

Understanding how carmustine and lomustine work, how they are given, and their side effects helps us use them better. This improves treatment for brain tumors and better outcomes for patients.

Surgical Interventions and Their Role in Treatment

For many patients with brain tumors, surgery is a key treatment. The goal is to remove as much of the tumor as possible. This is done while trying to keep the brain tissue and function safe.

Resection Techniques and Technology

New techniques and technology have made brain tumor surgeries better. We use:

  • Intraoperative MRI: This lets us see the tumor in real-time during surgery. It helps us remove more of the tumor.
  • Fluorescence-Guided Surgery: This method uses special dyes to show the tumor. It makes removing the tumor more accurate.
  • Neuro-navigation Systems: These systems help us find the tumor and important brain areas with precision.

Determining Surgical Candidacy

Deciding if surgery is right depends on several things. These include:

  1. Tumor Characteristics: We look at the tumor’s size, location, and type.
  2. Patient’s Overall Health: We check if the patient has other health issues and how their brain is working.
  3. Potential Benefits and Risks: We compare the good things surgery can do to the possible bad things.

Post-Surgical Medication Protocols

After surgery, we use medicine to help with recovery and prevent problems. This includes:

  • Anticonvulsants: These help prevent seizures.
  • Corticosteroids: They help reduce swelling and inflammation.
  • Antibiotics: These prevent or treat infections.

We also think about other treatments like chemotherapy and radiation. This depends on the tumor type and how much we could remove.

Radiation Therapy Options for Brain Tumors

Radiation therapy is key in treating brain tumors. It offers various options based on each patient’s needs. We aim to target tumor cells while keeping healthy tissue safe.

External Beam Radiation

External beam radiation therapy (EBRT) sends radiation from outside the body to the tumor. This method treats larger areas. It can be split into many sessions to lessen side effects.

We use EBRT for many brain tumors. We adjust the dose and how often it’s given based on the tumor and patient’s health.

Stereotactic Radiosurgery

Stereotactic radiosurgery (SRS) is not surgery but a precise radiation therapy. It uses tools like Gamma Knife and CyberKnife. This method gives a high dose of radiation to a small area, protecting the brain.

SRS works well for small, well-defined tumors. It’s a good choice for those not suited for regular surgery.

Proton Therapy Applications

Proton therapy uses protons instead of X-rays to kill cancer cells. It’s great for tumors near important areas. This method offers precise control over the radiation dose.

We use proton therapy for some brain tumors. It’s best for tumors near sensitive areas or in children. This helps reduce long-term side effects.

Knowing the different radiation therapy options helps patients and families make better choices. We aim to provide detailed treatment plans. These plans use the best radiation therapy methods for each person’s needs.

Innovative Approaches in Brain Tumor Treatment

The field of brain tumor treatment is changing fast. New methods are giving patients hope. As we learn more about brain tumors, we’re finding new ways to fight them.

Immunotherapy Developments

Immunotherapy uses the body’s immune system to fight cancer. It’s showing great promise in treating brain tumors. This method targets tumor cells carefully, protecting healthy tissue.

Checkpoint inhibitors are making a big impact. They help the immune system fight cancer better. CAR-T cell therapy is also promising. It changes a patient’s T cells to attack cancer cells, making treatment more personal.

Tumor Treating Fields (Optune)

Tumor Treating Fields (TTFields) is a new way to treat brain tumors. It uses electrodes on the scalp to send electric fields to tumors. These fields stop cancer cells from growing, helping patients live longer.

TTFields work best when used with other treatments. Combining it with chemotherapy and radiation can improve patient outcomes. This approach can make treatment more effective and better for patients’ quality of life.

Precision Medicine and Genetic Targeting

Precision medicine is changing how we treat brain tumors. It tailors treatments to each patient’s tumor. By studying the tumor’s genetics, we can find the best treatments.

Genetic targeting uses drugs that attack specific tumor weaknesses. This can slow or stop tumor growth. The development of glioblastoma drugs that target specific genetic mutations is a big step forward. It offers new hope for those with aggressive brain cancer.

Comprehensive Care at Specialized Centers Like Liv Hospital

Specialized centers like Liv Hospital focus on treating brain tumors in a unique way. They use a team approach to care for patients. This means all parts of a patient’s health are looked after, from start to finish.

Multidisciplinary Treatment Teams

At Liv Hospital, multidisciplinary treatment teams are key. These teams include neurosurgeons, neuro-oncologists, and more. They work together to create treatment plans that fit each patient’s needs.

  • Expert neurosurgeons and surgical teams
  • Neuro-oncologists specializing in brain tumor medication
  • Radiation oncologists with advanced technology
  • Supportive care specialists for rehabilitation and psychological support

Patient-Centered Care Approaches

Liv Hospital focuses on patient-centered care. They make treatment plans that fit each patient’s unique situation. This approach makes patients happier and helps them get better faster.

The patient-centered care model includes:

  1. Personalized treatment planning
  2. Comprehensive support services
  3. Access to innovative therapies and clinical trials
  4. Continuous monitoring and adjustment of treatment plans as needed

Access to Clinical Trials and Emerging Therapies

Getting care at Liv Hospital means access to new treatments. Patients can join research studies that offer new options. This is very important for those with hard-to-treat conditions.

Liv Hospital is always looking to improve medicine of the brain. They offer the latest in brain tumor treatment through research. Patients get to try new, possibly better treatments.

Conclusion: The Future of Brain Tumor Treatment

The field of brain tumor treatment is changing fast. New medicines and treatments are making a big difference for patients. We’ve talked about important drugs like Temozolomide, Bevacizumab, and Everolimus. We’ve also looked at how surgery and radiation therapy help.

New hope is on the horizon with ongoing research. Therapies like immunotherapy and tumor treating fields are being tested. At places like Liv Hospital, teams work together to offer the best care and latest treatments.

Looking ahead, precision medicine and genetic targeting will be key. We’re dedicated to top-notch healthcare for everyone. This includes support for patients from around the world, making sure they get the best treatments.

What are the most common medications used to treat brain tumors?

Common medications for brain tumors include temozolomide, bevacizumab, and everolimus. Also, carmustine and lomustine are used. The choice depends on the tumor type and stage.

How does temozolomide work in treating brain tumors?

Temozolomide damages cancer cells’ DNA. This stops them from growing and spreading. It’s a key treatment for glioblastoma.

What is the role of bevacizumab in brain tumor treatment?

Bevacizumab blocks blood vessels that feed tumors. This cuts off their nutrients and oxygen. It helps slow down glioblastoma growth.

Can brain tumors be treated with medication alone?

Medication is key, but treatment often includes surgery, radiation, and chemotherapy. The plan varies based on the tumor and patient’s health.

What are the side effects of brain tumor medications?

Side effects differ by drug and patient. Common ones are nausea, fatigue, hair loss, and infection risk. Managing these is important.

How is everolimus used in treating brain tumors?

Everolimus slows tumor growth by affecting cell growth. It’s used for SEGA, reducing tumor size and slowing growth.

What is vorasidenib, and how is it used in brain tumor treatment?

Vorasidenib targets IDH-mutated gliomas. It blocks the mutant IDH enzyme, slowing tumor growth. It shows promise in clinical trials.

What is the significance of IDH mutations in brain tumors?

IDH mutations affect some brain tumors, like gliomas. They influence tumor behavior and treatment. Targeted therapies like vorasidenib aim to treat these tumors.

How do carmustine and lomustine work in treating brain tumors?

Carmustine and lomustine damage cancer cells’ DNA. They slow tumor growth. They’re used in glioblastoma treatment, often with other drugs.

What are the benefits of receiving care at a specialized center like Liv Hospital?

Centers like Liv Hospital have expert teams and new treatments. They offer immunotherapy and precision medicine. This care can greatly improve outcomes.

What are the latest innovations in brain tumor treatment?

New treatments include immunotherapy, tumor treating fields, and precision medicine. These aim to better target tumors and improve outcomes.

  1. National Brain Tumor Society (NBTS). (n.d.). Treatment Options. Retrieved from https://braintumor.org/brain-tumors/diagnosis-treatment/diagnosis/treatment-options/
  2. National Cancer Institute (NCI). (n.d.). Drugs Approved for Brain Tumors. Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/brain
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75